col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


31 Results       Page 1

 [1] 
Portland Press: Bioscience Reports
  original article Date Title Authors   All Authors
1 [GO] 2024―Dec―10 Does COVID-19 impact the QT interval prolongation? Answers from genetic causal inference Yongfei Song, Zequn Zheng
2 [GO] 2024―Jul―24 Boosting Immunity: Synergistic Antiviral Effects of Luteolin, Vitamin C, Magnesium, and Zinc Against SARS-CoV-2 3CLpro Juliana C. Ferreira, Samar Fadl, Thyago H. S. Cardoso, Bruno Andrade, Tarcisio S. Melo, Edson M.A. Silva, et al. (+4)
3 [GO] 2024―Jul―22 3C-like proteases in SARS-CoV-2 Kenana Al Adem, Juliana C. Ferreira, Adrian J. Villanueva, Samar Fadl, Farah El-Sadaany, Imen Masmoudi, et al. (+5)
4 [GO] 2023―Dec―22 SARS-CoV-2 NSP14 MTase activity is critical for inducing canonical NF-κB activation Marie J Tofaute, Benjamin Weller, Carina Graß, Hridi Halder, Bushra Dohai, Pascal Falter-Braun, Daniel Krappmann
5 [GO] 2023―Jul―27 Surfactant Replacement Therapy as Promising Treatment for COVID-19: an Updated Narrative Review Khaled Kh�h, Alaa Ramadan, Ahmed Othman, Neveen Refaey, Amr Alrosasy, Ayoub Rezkallah, et al. (+6)
6 [GO] 2023―Jul―24 The kynurenine pathway of tryptophan metabolism: a neglected therapeutic target of COVID-19 pathophysiology and immunotherapy Abdulla Abu-Bakr Badawy
7 [GO] 2023―May―22 COVID-19 Associated Thyroid Dysfunction and Other Comorbidities and Its Management Using Phytochemical-Based Therapeutics- A Natural Way Arpana Parihar, Shivani Malviya, Raju Khan, Ajeet Kaushik, Ebrahim Mostafavi
8 [GO] 2023―Mar―06 Acid-Base Imbalance as a Risk Factor for Mortality among COVID-19 Hospitalized Patients Nosayba Al-Azzam, Basheer Khassawneh, Sayer Al-Azzam, Reema Karasneh, Mamoon A Aldeyab
9 [GO] 2023―Jan―18 Polypharmacology of ambroxol in the treatment of COVID-19 Ziyuan Wang, Minghui Yang, Xi Chen, Rongxin Xiao, Yu Dong, Ming Chu, et al. (+2)
10 [GO] 2021―Sep―14 Targeting Intra-Viral Conserved Nucleocapsid (N) Proteins as Novel Vaccines against SARS-CoVs Min Thura, Joel Xuan En Sng, Koon Hwee Ang, Jie Li, Abhishek Gupta, Jimmy Ming Hong, et al. (+2)
11 [GO] 2021―Aug―05 Obesity, a major risk factor for immunity and severe outcomes of COVID-19 Mohammad Tohidul Amin, Kaniz Fatema, Sayama Arefin, Fahad Hussain, Dipty Rani Bhowmik, Mohammad Salim Hossain
12 [GO] 2021―Jul―30 SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: Implications for microclot formation in COVID-19 Lize M Grobbelaar, Chantelle Venter, Mare Vlok, Malebogo Ngoepe, Gert J Laubscher, Petrus J Lourens, et al. (+3)
13 [GO] 2021―Jul―27 A lipidomic view of SARS-CoV-2 Kourosh Honarmand Ebrahimi, James McCullagh
14 [GO] 2021―Jul―22 Biochemical composition, transmission and diagnosis of SARS-CoV-2 Rajesh Ahirwar, Sonu Gandhi, Komal Komal, Geeta Dhaniya, Prem Prakash Tripathi, Vyas Madhavrao Shingatgeri, et al. (+3)
15 [GO] 2021―Jul―01 Increased sTREM-1 plasma concentrations are associated with poor clinical outcomes in patients with COVID-19 Aline H de Nooijer, Inge Grondman, Simon Lambden, Emma J Kooistra, Nico AF Janssen, Matthijs Kox, et al. (+6)
16 [GO] 2021―Jun―16 Heparanase as a Potential Player in SARS-CoV-2 Infection and Induced-Coagulopathy Safa Kinaneh, Iyad Khamaysi, Tony Karram, Shadi Hamoud
17 [GO] 2021―Feb―26 Lipidomic Alteration of Plasma in Cured COVID-19 Patients using UltraHigh-Performance Liquid Chromatography with High-Resolution Mass Spectrometry Yunpeng Bai, Wendong Huang, Yaocai Li, Changchun Lai, Sumei Huang, Guangwen Wang, et al. (+3)
18 [GO] 2021―Feb―24 Knowing and combating the enemy: a brief review on SARS-CoV-2 and computational approaches applied to the discovery of drug candidates Mateus S.M. Serafim, Jadson C. Gertrudes, Débora M. A. Costa, Patricia R. Oliveira, Vinicius G. Maltarollo, Kathia Maria Honorio
19 [GO] 2021―Feb―24 The SARS-CoV-2 induced targeted amino acid profiling in patients at hospitalized and convalescent stage Junfang Wu, Mingming Zhao, Chenze Li, Yuxuan Zhang, Dao Wen Wang
20 [GO] 2021―Feb―23 Correction: Network pharmacology for the identification of phytochemicals in traditional Chinese medicine for COVID-19 that may regulate interleukin-6
21 [GO] 2021―Jan―23 Hyperglycaemia at admission is a strong predictor of mortality and severe/critical complications in COVID-19 patients: A meta-analysis Yan Yang, Zixin Cai, Jingjing Zhang
22 [GO] 2021―Jan―14 ACE/ACE2 balance might be instrumental to explain the certain comorbidities lead to severe COVID-19 cases Sarbashri Bank, Subrata Kumar De, Biswabandhu Bankura, Smarajit Maiti, Madhusudan Das, Gausal A Khan
23 [GO] 2020―Dec―22 Sex differences in immune responses to SARS-CoV-2 in patients with COVID-19 Guolian Zhao, Yazhou Xu, Jing Li, Xiaoli Cui, Xiaowen Tan, Hongyue Zhang, Liyun Dang
24 [GO] 2020―Dec―11 Structural assessment of SARS-CoV2 accessory protein ORF7a predicts LFA-1 and Mac-1 binding potential Zubair A Nizamudeen, Emma-Ruoqi Xu, Vivin Karthik, Mohamed Halawa, Kenton P Arkill, Andrew Jackson, et al. (+2)
25 [GO] 2020―Nov―30 Low serum calcium: a new, important indicator of COVID-19 patients from mild/moderate to severe/critical Xi Zhou, Dong Chen, Lan Wang, Yuanyuan Zhao, Lai Wei, Zhishui Chen, Bo Yang
26 [GO] 2020―Nov―17 Prognostic factors and predictors of outcome in patients with COVID-19 and related pneumonia: a retrospective cohort study. Gianluca E.M. Boari, Giulia Chiarini, Silvia Bonetti, Paolo Malerba, Gianluca Bianco, Cristina Faustini, et al. (+14)
27 [GO] 2020―Nov―04 Network pharmacology for the identification of phytochemicals in traditional Chinese medicine for COVID-19 that may regulate interleukin-6 Chun Liang, Wenhao Niu, Feng Wu, Wenyue Cao, Zonggui Wu, Yu Chieh Chao, Fei Peng
28 [GO] 2020―Oct―16 Immunotherapy of COVID-19 with poly (ADP-ribose) polymerase inhibitors: starting with nicotinamide? Abdulla A-B Badawy
29 [GO] 2020―Jul―29 Blood routine test in mild and common 2019 coronavirus (COVID-19) patients Dodji Kossi Djakpo, Zhiquan Wang, Rong Zhang, Xin Chen, Peng Chen, Malyn Martha Lilac ketisha Antoine
30 [GO] 2020―May―22 Glecaprevir and Maraviroc are high-affinity inhibitors of SARS-CoV-2 main protease: Possible therapeutic implication in COVID-19 Anas Shamsi, Taj Mohammad, Saleha Anwar, Mohamed Alajmi, Afzal Hussain, Md. Tabish Rehman, et al. (+2)
31 [GO] 2020―May―07 A virus that has gone viral: Amino-acid mutation in S protein of Indian-isolate of Coronavirus COVID-19 might impact receptor-binding, thus infectivity Priyanka Saha, Arup Kumar Banerjee, Prem Prakash Tripathi, Amit Kumar Srivastava, Upasana Ray
 [1] 

31 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec